Max Robotics — Global Service Robot Directory + US Certification

About

Ignasi Poves is a leading figure in pancreatic surgery, whose research has fundamentally reshaped how surgeons approach pancreatoduodenectomy—one of the most complex abdominal operations. His work centers on comparing minimally invasive techniques (laparoscopic, robotic, and hybrid) with traditional open surgery, and on predicting and preventing the procedure’s most feared complication: postoperative pancreatic fistula. Poves’s landmark 2018 study, with 159 citations, provided crucial pan-European evidence that minimally invasive pancreatoduodenectomy (MIPD) is safe and offers short-term benefits over open surgery when performed at high-volume centers. Building on this, his 2019 paper (195 citations) introduced the updated Alternative Fistula Risk Score (ua-FRS), a validated tool that optimizes risk prediction specifically for MIPD patients. This score now guides surgeons worldwide in tailoring postoperative care and reducing fistula-related morbidity. As a key contributor to the European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS), Poves has driven the shift toward evidence-based, patient-centered innovation in pancreatic surgery, making his work essential reading for any surgeon or researcher seeking to improve outcomes in this challenging field.